Pylarify injections
Ended Awarded Last action
- Contract number
- 36C24823N0536
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $844,440
Award facts
- Contract value 100% obligated
- $844,440.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$635,135 | |
| Supplemental Agreement for work within scope | $541,308 | |
| Original award | $938,267 |
About this award
This is a firm fixed price contract awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for positron emission tomography (PET) imaging of prostate cancer. The contract has a ceiling value of $844,440.48 and a period of performance through December 31, 2023. This contract is not set aside for any specific business type. Progenics Pharmaceuticals specializes in developing and supplying innovative diagnostic imaging agents and targeted therapeutics, primarily to government healthcare agencies like the VA and the Defense Health Agency (DHA). The company holds several Blanket Purchase Agreements (BPAs) with these agencies to facilitate the ongoing procurement of PYLARIFY and other radiopharmaceuticals for cancer detection and treatment.
Quick answers
Who was awarded contract 36C24823N0536?
36C24823N0536 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on April 1, 2023.
How much is contract 36C24823N0536 worth?
The government has obligated $844,440 on 36C24823N0536.
Is contract 36C24823N0536 an order under another contract?
Yes. 36C24823N0536 is a BPA call under 36F79719D0170-36C24823A0018, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24823N0536 competed?
The extent of competition for 36C24823N0536 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award